Immunology News and Research

Latest Immunology News and Research

UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health awarded the UNC Gillings School of Global Public Health a $65 million grant establishing an Antiviral Drug Discovery Center to develop oral antivirals that can combat pandemic-level viruses like COVID-19.

20 May 2022

Studies provide insight into how long COVID-19 immunity lasts and nature of immune recall

How does the immune system remember and recognize viral invaders it has encountered in the past? A trio of newly published studies of people infected with SARS-CoV-2, vaccinated against the virus or both, are providing tantalizing new clues about the factors that influence the speed and magnitude of the immune system's response to subsequent infection with variants of SARS-CoV-2.

19 May 2022

Mice study links dietary cholesterol with exacerbation of influenza

New research from the University of Illinois suggests high levels of dietary cholesterol make mice sicker when infected with influenza. The study is the first to link cholesterol in the diet with exacerbation of a viral infection.

19 May 2022

Study identifies cancer biomarkers based on a type of genetic modification

Biomarkers are often used during the management of cancer to guide treatment decisions and predict patient outcomes. However, it is often difficult to identify appropriate biomarkers that can be consistently reproduced and are easily analyzed with limited patient specimens.

18 May 2022

Camelid IFNs could play important role in combating emerging zoonotic pathogens

In a recent study published in the Developmental & Comparative Immunology journal, the discovery of a novel form of mammalian interferon-Beta (IFN-β) with four cysteine residues from the dromedary camel and the five remaining members of the mammalian suborder Tylopoda is described.

17 May 2022

3rd dose of COVID mRNA vaccine expands memory and capacity of immune system to combat Omicron

Researchers from the United States have now found that the immune recall induced by a two-dose primary series of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination after an initial natural infection highly improves the longevity of the antibodies as well as induces an enhanced breadth of protection across the SARS-CoV-2 variants.

17 May 2022

Origin, evolution and ecological relationships of yeasts

Yeasts have been evolving and diversifying for more than 400 million years. Likely, symbiotic relationships between humans and yeasts started already at the origin of our species (200-300 thousand years ago).

17 May 2022

Researchers explore COVID-19 vaccination in immunocompromised individuals

A new study discusses the safety and efficacy of the COVID-19 vaccination and potential strategies to optimize protection in patients with impaired immunity.

17 May 2022

A study of SARS-CoV-2-mRNA booster vaccinations in immunocompromised patients

In a recent study published in the journal Frontiers in Immunology, researchers assessed the immune responses induced by vaccination with the messenger ribonucleic acid (mRNA)-1273 vaccine or the BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections among immunocompromised individuals.

17 May 2022

Sentiment toward COVID-19 vaccines previews subsequent vaccination rates, Twitter study finds

Sentiments toward COVID-19 vaccines, whether positive or negative, previews subsequent vaccination rates, finds a study of related Twitter posts.

15 May 2022

Novel Type 1 diabetes treatment involves pancreatic islet transplant without the need for immunosuppression

In a new study, a team of researchers from the University of Missouri, Georgia Tech and Harvard University has demonstrated the successful use of a novel Type 1 diabetes treatment in a large animal model.

13 May 2022

New mouse model shows the connection between stress, depression and cardiovascular disease risk

Results from a new mouse model may aid in understanding how depression and prolonged and severe stress increase the risk of cardiovascular disease, according to preliminary research presented at the American Heart Association's Vascular Discovery: From Genes to Medicine Scientific Sessions 2022.

13 May 2022

Antibiotics disrupt the immune system in the gut leading to fungal infection

Patients prescribed antibiotics in hospital are more likely to get fungal infections because of disruption to the immune system in the gut, according to a new study from the University of Birmingham and National Institutes of Health.

13 May 2022

Investigating effectiveness of mRNA booster against SARS-CoV-2 Omicron in individuals primed with mRNA or inactivated virus vaccines

Scientists have determined the effectiveness of different vaccination regimens in eliciting humoral immune responses against the SARS-CoV-2 Omicron variant.

13 May 2022

T-cell responses after COVID-19 and vaccinations

A new study published in the journal Frontiers in immunology examines the cell-mediated immunity in BNT162b2 COVID-19 mRNA vaccinated health care workers and COVID-19 patients.

12 May 2022

Study shows how MS patients treated with Rituximab react to COVID-19 vaccination

MS patients treated with Rituximab have better responses to the COVID-19 vaccine if they have higher B cell counts.

12 May 2022

Mitochondrial respiratory chain is essential for NLRP3 inflammasome activation

Northwestern Medicine investigators recently discovered that the mitochondrial respiratory chain — a series of protein complexes essential for a cellular respiration and energy production — is necessary for the activation of another protein complex linked to inflammation and the progression of chronic diseases, according to a study published in Nature Immunology.

12 May 2022

Immunology News and Research

Latest Immunology News and Research

UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

Studies provide insight into how long COVID-19 immunity lasts and nature of immune recall

Mice study links dietary cholesterol with exacerbation of influenza

Study identifies cancer biomarkers based on a type of genetic modification

Camelid IFNs could play important role in combating emerging zoonotic pathogens

3rd dose of COVID mRNA vaccine expands memory and capacity of immune system to combat Omicron

Origin, evolution and ecological relationships of yeasts

Researchers explore COVID-19 vaccination in immunocompromised individuals

A study of SARS-CoV-2-mRNA booster vaccinations in immunocompromised patients

Sentiment toward COVID-19 vaccines previews subsequent vaccination rates, Twitter study finds

Novel Type 1 diabetes treatment involves pancreatic islet transplant without the need for immunosuppression

New mouse model shows the connection between stress, depression and cardiovascular disease risk

Antibiotics disrupt the immune system in the gut leading to fungal infection

Investigating effectiveness of mRNA booster against SARS-CoV-2 Omicron in individuals primed with mRNA or inactivated virus vaccines

T-cell responses after COVID-19 and vaccinations

Study shows how MS patients treated with Rituximab react to COVID-19 vaccination

Mitochondrial respiratory chain is essential for NLRP3 inflammasome activation

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

Research reveals how a leaky gut leads to inflammation in the lungs

Predictive marker and potential treatment option for IBD discovered

Immunology eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research